To test the hypothesis that elevated plasma levels of natriuretic peptides may serve to
identify patients with left ventricular (LV) dysfunction, we assessed the predictive diagnostic …

We have directly compared atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP),
and N-terminal pro-ANP (N-ANP) as markers of patients with left ventricular ejection fraction …

There is evidence that natriuretic peptide (namely atrial and/or B-type natriuretic peptides)
plasma concentration may be elevated in many clinical conditions besides cardiovascular …

Atrial and brain natriuretic peptides (ANP and BNP) are produced by the heart, and their
plasma concentrations are increased in human chronic congestive heart failure. Although …

Assays for natriuretic peptides have received considerable attention as potential screening
tests for congestive heart failure and left ventricular dysfunction. However, information …

1. The major cardiovascular and renal actions of α-atrial natriuretic peptide (ANP) and brain
natriuretic peptide (BNP) and the fact that the heart is strategically located to sense changes …

Background: Plasma natriuretic peptide levels may be useful in the diagnosis of heart
failure. The available natriuretic peptide assays differ markedly in their performance …

The heart secrets two different natriuretic peptides, atrial natriuretic peptide (ANP) and brain
natriuretic peptide (BNP), which have potent vasorelaxant, diuretic, and natriuretic actions …

In the present study, we assessed the use of urinary natriuretic peptides [N-terminal proatrial
natriuretic peptide (N-ANP) and N-terminal pro-brain natriuretic peptide (N-BNP) and C-type …

The present study was designed to investigate whether brain natriuretic peptide (BNP) and
atrial natriuretic peptide (ANP) plasma concentrations correlate with left ventricular end …